Exhibit 11 INNOVIR LABORATORIES, INC. AND SUBSIDIARIES (A DEVELOPMENT STAGE ENTERPRISE) STATEMENT OF COMPUTATION OF PER SHARE DATA FOR THE THREE MONTHS FOR THE SIX MONTHS ENDED JUNE 30, ENDED JUNE 30, --------------------------- --------------------------- 1997 1996 1997 1996 ----------- ----------- ----------- ----------- PRIMARY: Net loss $(2,534,000) $(3,335,000) $(5,031,000) $(3,884,000) =========== =========== =========== =========== Per share data: Weighted average number of common shares outstanding 18,051,000 9,500,000 18,053,000 9,500,000 ----------- ----------- ----------- ----------- Net loss per share (0.14) (0.35) (0.28) (0.41) =========== =========== =========== =========== FULLY DILUTED: Net loss $(2,534,000) $(3,335,000) $(5,031,000) $(3,884,000) =========== =========== =========== =========== Per share data: Weighted average number of common shares outstanding during the period 18,051,000 9,500,000 18,053,000 9,500,000 Shares issuable upon conversion of convertible equity securities 9,121,000 8,667,000 9,121,000 8,667,000 Shares issuable upon exercise of outstanding options and warrants 3,001,000 2,000,000 3,008,000 2,000,000 Shares assumed to be repurchased under the treasury stock method (1,821,000) (783,000) (1,824,000) (801,000) ----------- ----------- ----------- ----------- Number of common shares used in computing per share data 28,352,000 19,384,000 28,358,000 19,366,000 ----------- ----------- ----------- ----------- Net loss per share $ (0.09) $ (0.17) $ (0.18) $ (0.20) =========== =========== =========== =========== -13-